<bill session="117" type="s" number="4333" updated="2022-12-29T16:48:33Z">
  <state datetime="2022-05-26">REFERRED</state>
  <status>
    <introduced datetime="2022-05-26"/>
  </status>
  <introduced datetime="2022-05-26"/>
  <titles>
    <title type="display">CLEAR Act</title>
    <title type="short" as="introduced">CLEAR Act</title>
    <title type="short" as="introduced">Consistent Legal Evaluation And Regulation of Medical Products Act</title>
    <title type="official" as="introduced">A bill to deem certain products regulated by the Food and Drug Administration as drugs.</title>
  </titles>
  <sponsor bioguide_id="S001203"/>
  <cosponsors>
    <cosponsor bioguide_id="M001198" joined="2022-05-26"/>
  </cosponsors>
  <actions>
    <action datetime="2022-05-26">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2022-05-26" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="117" type="h" number="7667" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2022-10-18T14:57:18Z" status="Introduced in Senate">Consistent Legal Evaluation And Regulation of Medical Products Act or the CLEAR Act

This bill requires the Food and Drug Administration to regulate contrast agents for medical imaging devices, radioactive drugs, over-the-counter monograph drugs, and ophthalmic drug articles (i.e., eye droppers) as drugs rather than medical devices.</summary>
</bill>
